Blood filtering device for severe lung infection with breathing support
Part of Infections, Lungs & breathing clinical trials.
This study tests a device that filters blood to remove harmful pieces of DNA that can worsen sepsis. It aims to see if this treatment is safe and helps patients with severe lung infections who are on a breathing machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 75 years
- Suspected or confirmed lung infection leading to sepsis
- Currently on a breathing machine (intubated) for no more than 48 hours
- Very low oxygen levels in the blood despite oxygen therapy
- Severity of illness within a certain range (not too mild, not too severe)
- Stable enough to give informed consent (or a legal representative can)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a blood-filtering treatment for people in septic shock, a severe reaction to infection. It aims to see if removing harmful substances from the blood can help recovery.
This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.
This trial looks at whether a blood-filter treatment (called “AN69ST Verse PS” using a hemofilter) can help children with early, serious sepsis and poor circulation or organ problems. It may help stabilize the body faster, but eligibility is limited to certain sepsis situations and recent timing.
This trial tests whether removing extra DNA from the blood can help people with septic shock. It aims to reduce inflammation and improve outcomes for those with high DNA levels.
This trial tests a new treatment to protect and repair the layer of cells lining your blood vessels (glycocalyx) during sepsis. It aims to improve recovery from severe infections.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.